| 貨號 | 規格 | 價格 | 上海 | 北京 | 武漢 | 南京 | 購買數量 |
|---|---|---|---|---|---|---|---|
S87409-1mg |
99.6% | ￥190.40 | 5 | - | - | - |
|
S87409-2mg |
99.6% | ￥272.00 | 5 | - | - | - |
|
S87409-5mg |
99.6% | ￥469.20 | 5 | - | - | - |
|
S87409-10mg |
99.6% | ￥612.00 | 6 | - | - | - |
|
S87409-25mg |
99.6% | ￥1190.00 | 4 | - | - | - |
|
S87409-50mg |
≥99% | ￥2176.00 | 貨期：2-3天 | - | - | - |
|
S87409-100mg |
≥99% | ￥4148.00 | 貨期：2-3天 | - | - | - |
|
FIPI is a derivative of halopemide which potently inhibits both PLD1 and PLD2 with IC50s of 25 nM and 20 nM, respectively.
| 產品描述： | FIPI is a derivative of halopemide which potently inhibits both PLD1 and PLD2 with IC50s of 25 nM and 20 nM, respectively. | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶點： | IC50: 25 nM (PLD1), 20 nM (PLD2);Phospholipase;?Autophagy | ||||||||||||||||||||
| 參考文獻： | 1. Monovich L, et al. Optimization of halopemide for phospholipase D2 inhibition. Bioorg Med Chem Lett. 2007 Apr 15;17(8):2310-1. 2. Su W, et al. 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis. Mol Pharmacol. 2009 Mar;75(3):437-46. 3. Secor JD, et al. Novel lipid-soluble thiol-redox antioxidant and heavy metal chelator, N,N'-bis(2-mercaptoethyl)isophthalamide (NBMI) and phospholipase D-specific inhibitor, 5-fluoro-2-indolyl des-chlorohalopemide (FIPI) attenuate mercury-induced lipid si | ||||||||||||||||||||
| 溶解性： | Soluble in DMSO | ||||||||||||||||||||
| 保存條件： | 2-8℃ | ||||||||||||||||||||
| 配置溶液濃度參考： |
|
||||||||||||||||||||
| 注意： | 部分產品我司僅能提供部分信息，我司不保證所提供信息的權威性，僅供客戶參考交流研究之用。 |
上海工商
滬公網安備 31011702002021號
危險品化學品經營許可證（不帶存儲）
營業執照(三證合一)
北京